Nest Genomics

Nest Genomics

Private
New York City, New YorkHealthcare & Life Scienceshttps://nestgenomics.com

Last Round

Seed

Jan 10, 2023

Total Funding Raised

$8.5M

Momentum Score

50 /100

Company Overview

Nest Genomics is a health technology company that provides a software platform for healthcare organizations to integrate and scale genomic programs. Its turnkey solution, which is EMR-integrated, facilitates patient identification, clinical decision support, and provides educational resources for both providers and patients. The company aims to make it easier for health systems to launch and scale precision medicine by incorporating genetic information into provider workflows and patient care. Founded in 2022 by serial entrepreneurs Moran Snir and Guy Snir, the company has raised $9 million in funding from investors including B Capital and Y Combinator. Nest Genomics is headquartered in New York with offices in San Francisco and Tel Aviv.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, EHR & EMR, Vertical SaaS, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

genetics copilotgenomics software platformEMR integrationEHR integrationclinical decision supportCDSgenomic data integrationprecision medicine platformpoint of care geneticsgenomic risk assessmentlab-agnostic platformpersonalized medicine softwareclinical workflow automationhereditary cancer screeningcardiovascular geneticspatient identificationAI for genomicspatient engagement toolshealthcare analyticshealthcare SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nest Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nest Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 10, 2023

Key People

Founding team and executive leadership

Guy Snir

Co-Founder COO

Founding Team

Nest Genomics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Added Mychartatradychildrens, an enterprise healthcare company, as a customer.

  • Feb 1, 2026

    Added Dana-Farber Cancer Institute as a customer.

Nest Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nest Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nest Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range16
Year Founded2022
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.